Preoperative Cataract Pupillary Dilation: Inpatient At The Ambulatory Surgery Center vs Outpatient Dilation Prior To Arrival At The Ambulatory Surgery Center

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01169688
Recruitment Status : Completed
First Posted : July 26, 2010
Last Update Posted : July 26, 2010
Information provided by:
Northwest Kansas Surgery Center

Brief Summary:
This study was done to compare efficacy, safety and efficiencies of various methods of pupil dilation prior to cataract surgery.

Condition or disease Intervention/treatment Phase
Pupil Dilation Prior to Cataract Surgery In-patient Pupil Dilation Prior to Cataract Surgery Out-patient Other: Pupil dilation with phenylephrine 10% vs cyclopentolate 2% Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Preoperative Cataract Pupillary Dilation: Inpatient vs Outpatient
Study Start Date : December 2007
Actual Primary Completion Date : April 2008
Actual Study Completion Date : April 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cataract
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Ability to self administer eye or have a helper for the task of administering eye drops.
  • Ability to follow and eye drop administration schedule.
  • No noted ocular abnormalities.
  • Bilateral cataract surgery anticipated.

Exclusion Criteria:

  • Inability to self administer eye drops or have assistance with eye drop administration.
  • Health problems that would contraindicate self administration of dilating eye drops such as poor cardiovascular or respiratory status.

Responsible Party: Ronald Holweger MD, Northwest Kansas Surgery Center Identifier: NCT01169688     History of Changes
Other Study ID Numbers: NWKSC_2007_01
First Posted: July 26, 2010    Key Record Dates
Last Update Posted: July 26, 2010
Last Verified: December 2007

Keywords provided by Northwest Kansas Surgery Center:
Cataract Surgery
Pupillary Dilation

Additional relevant MeSH terms:
Dilatation, Pathologic
Lens Diseases
Eye Diseases
Pathological Conditions, Anatomical
Pupil Disorders
Cardiotonic Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Vasoconstrictor Agents
Nasal Decongestants
Respiratory System Agents
Adrenergic alpha-1 Receptor Agonists
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Protective Agents
Muscarinic Antagonists
Cholinergic Antagonists
Cholinergic Agents